AMRI has a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies. We offer more than 240 high-quality, competitively priced APIs and intermediates, including generics, that cover a variety of therapeutic areas.

AMRI Key Product Families

Monobactams
  • Manufacturer of Aztreonam, both Oral APIs and Sterile
  • Dedicated plant
Steroids
  • Dedicated Plant
  • Hydrogenation
  • Phosphates
  • Lyophilization
  • Mill Unit
  • Micronization Unit
Hormones
  • Dedicated Plant
  • Containment Technology
  • Mill Unit
  • Micronization Unit
Other Niche Products
  • Ergot Derivatives
  • Immunosuppressant
  • High Potent compounds
  • Curares
  • Tetracyclines
  • Prostaglandins
Controlled Substances
  • 4 DEA manufacturing areas
  • Research and export registration for schedules I, II & V

View API Catalog

Inquire for information about therapeutic class and DMF registration.

LET’S GET STARTED